|Malaria is a disease which is prevelant in South America, Sub Saharan Africa and South East Asia. Within the past decade, through a use of chemoprohylaxis and mosquito eradication there has been a 29% reduction in malaria mortality rates globally. Sub-Saharan Africa continues to carry a disproportionately high share of the global malaria burden. In 2015, the region was home to 90% of malaria cases and 92% of malaria deaths.|
HubNet.io offers a Malaria Chemoprophylaxis PGD which enables registered healthcare professionals (non-prescribing pharmacists and nurses) to supply three different medicines for the protection against malaria, these include:
Between 2000 and 2015 the global incidence of malaria decreased by 37% overall, with the majority of cases in 2015 occurring in the WHO Africa and Asia regions. Never the less, the Health Protection Agency (HPA) figures for 2013 showed that of cases of malaria imported into the UK, 1,192 were due to Plasmodium falciparum, 179 were due to P. vivax, 78 to P. ovale and 39 to P. malariae. There were seven deaths.
Anti malarial’s or chemoprophylaxis of malaria can reduce the patients chance of contracting malaria by about 90%. The patient should be reminded that no malaria prevention tablets are considered 100% effective. The choice of which antimalarial to choose is based upon:
Our training materials have been created by practicing pharmacists working in community pharmacy.
Hubnet is an online pharmacy information system. We intend to provide healthcare professionals with an online ecosystem to allow for better communication between each other and their patients. Protected by law, the data you enter into this site remains your intellectual property and cannot be used by us. Our goal is to enable you to do more, if you like it you can subscribe for more!